News

Wegovy, a weight loss drug which reduces cardiovascular risks in obese individuals, launched in India on June 24. Experts break down its benefits and risks.
Plain Facts compilation, we present to you data-based insights, with easy-to-read charts, to help you delve deeper into the ...
Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...
A fast-growing group of Americans are turning to what many call the "gray market" for obesity medicines, bringing cheap ...
Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...
GPs will be prescribing Mounjaro to a select few people as the rollout begins, but others may need to avoid the jabs ...
Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...
The Mounjaro weight-loss jab is now available from GPs the NHS, but only for a limited group of patients with a BMI over 35 ...
Facing limited insurance coverage and unaffordable prices for drugs like Wegovy and Zepbound, Americans are importing active ...
Jenny Mollen, Jason Biggs’ wife, shared how microdosing GLP1 medication led to an ER visit and raised concerns about mental health effects ...
Thousands are now eligible to get Mounjaro through the NHS, but some may need to avoid it and it might not even work for ...
Dr Willie told Reach: “You should speak to your doctor about any conditions or medications before taking any weight loss ...